Pfizer Inc. (PFE), the worlds biggest drugmaker, will pay closely held Bind Therapeutics Inc. as much as $200 million per potential drug to develop medicines using its nanotechnology platform.

The companies will collaborate on preclinical work and New York-based Pfizer will have the option to pursue development of compounds it selects, Bind said in a statement today. The Cambridge, Massachusetts-based company may receive as much as $50 million in upfront and development payments and is eligible for $160 million more per compound tied to regulatory and sales goals.

The deal is the second this year for Bind, which uses nanotechnology to selectively reach disease sites in the body in treating cancer, inflammatory ailments and cardiovascular disorders without affecting healthy tissue. In January, Amgen Inc. said it would pay as much as $180.5 million for the right to develop cancer drugs using Binds technology.

The pharmaceutical industry is reaching an inflection point in terms of adopting this as a major strategic technology for the industry, Bind Chief Executive Officer Scott Minick said in an interview.

Binds technology comes from the laboratories of Robert Langer at the Massachusetts Institute of Technology and Omid Farokhzad, of Harvard Medical School. Its nanoparticles, which it calls Accurins, can travel through the body without being detected or destroyed by the immune system, Minick said. Carrying potent drugs, the particles home in on specific disease cells and avoid poisoning healthy ones.

In addition to partnerships with Pfizer and Thousand Oaks, California-based Amgen, Bind is developing a slate of potential drugs in-house. The companys leading therapy is BIND-014, which targets tumors with the cancer drug docetaxel. Bind said last week it will present results from a first-stage study of the treatment at the American Association for Cancer Research meeting on April 9.

Pfizer partnered with Bind because these delivery systems are a unique approach that potentially offer highly precise targeted therapeutics increasing the window for broader patient treatment options, said Lauren Starr, a spokeswoman for the drugmaker.

Pfizer declined less than 1 percent to $29.03 at the close in New York. The shares have increased 16 percent this year.

To contact the reporters on this story: Drew Armstrong in New York at darmstrong17@bloomberg.net; Meg Tirrell in New York at mtirrell@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Excerpt from:

Pfizer to Pay Bind Up to $210 Million in Nanotechnology Deal

By Associated Press

BIND Therapeutics said Wednesday that Pfizer Inc. has agreed to pay it $160 million per drug as part of a collaboration to develop targeted medicines using nanotechnology which use particles measured in billionths of a meter.

BIND is developing an experimental group of targeted, programmable medicines called Accurins to treat cancer, heart disease, and inflammatory disorders. The privately held companys technology comes from two laboratories that specialize in nanotechnology at Harvard Medical School and the Massachusetts Institute of Technology.

Pfizer will make initial payments of roughly $50 million, plus $160 million in regulatory and milestone payments for each targeted drug, according to an announcement from BIND.

Both companies will work on early-stage research for the drugs, and Pfizer will have the exclusive option to develop and market any products produced from the collaboration.

BIND has one product in early-stage clinical testing called Bind-014, a targeted Accurin that contains the chemotherapy drug docetaxel. The product is designed to attach itself to a protein that is expressed in some cancer cells and new blood vessels that feed tumors.

In an unrelated announcement Wednesday, the Childrens Hospital of Philadelphia said it will collaborate with Pfizer on therapies for children. Pfizer has research relationships with 21 academic hospitals throughout the U.S. with the aim of developing new products.

Visit link:

Pfizer inks deal with BIND Therapeutics, a Cambridge nanotechnology drugmaker

Nanotechnology that is, working with matter at the scale of atoms and molecules shows great promise for meeting challenges involved in understanding and utilizing the harder-to-reach oil and gas reservoirs of today. Thats according to scientists at the Advanced Energy Consortium (AEC), a research organization that develops micro- and nano-sensors to transform understanding of subsurface oil and natural gas reservoirs. The University of Texas at Austins Bureau of Economic Geology at the Jackson School of Geosciences manages the AEC. Two AEC scientists, Jay Kipper and Sean Murphy, spoke with EarthSky about how the success of nanomaterials in diverse fields such as medicine and automotives is being applied to petroleum science.

Lets begin with some basics. What is nanotechnology?

Jay Kipper: The prefix nano, from the Latin word nanus for dwarf, means something very small. When were using it in metric terms, a nanometer is one-billionth of a meter. Think about that! Take a strand of hair and put at it between your fingers. The width of that hair is 100,000 nanometers. If you put three atoms of gold side-by-side, thats a nanometer in width. A nanometer is about how much your fingernail grows every second. So a nanometer is really small. It was IBM in the late 1980s that invented the scanning tunneling microscope needed to image individual atoms that really initiated the field of nanoscience. Today, you might say nanotechnology is the application or use of nanoscience to manipulate, control and integrate atoms and molecules to form materials, structures, components, devices and systems at the nanoscale the scale of atoms and molecules.

Why is the oil and gas industry interested in nanotechnology?

Jay Kipper: There are a couple of answers to that question. First, looking at it from the perspective of science, whats really intriguing and fundamental about nanomaterials and nanotechnology is the size of the materials that were studying. The incredibly small size of these nanoscale materials creates opportunities for them to be injected into oil and gas reservoirs.

Microscope slide of the oil-bearing Frio Sandstone from Liberty County, Texas at a depth of 5040 feet. The pink grains are quartz particles, the blue material is a dye which highlights the volume of open pore space through which oil and brines flow freely. Photo courtesy of Bob Loucks, Bureau of Economic Geology, Univ. of Texas.

As readers know, oil and gas is commonly found in rocks that are buried thousands of feet underground. These rocks are constructed like sponges. Even though a rock might look like its solid, it really has many pathways for fluids to flow through freely. The spaces between these sand grains and cemented grains are called pore space and pore throats by geoscientists. Geoscientists have analyzed enough of these oil-bearing sandstones to establish that the pore throat openings commonly range between 100 and 10,000 nanometers in width. Thats large enough for fluids like water, brines, and oil and gas to flow through relatively freely. So if we could put nanoscale tracers or sensors down a hole, they would be small enough to flow through these pores, and we could gain a bunch of valuable information about the rock and the fluid environment where the oil and gas is found.

Whats exciting about nanoscale materials is that, chemically, they behave differently from bulk materials. Theyre sort of magical in many ways. For example, dropping metal powders into water results in all the particles sinking to the bottom or floating to the top, but stable nanoparticles stay in suspension in the fluids, and thats very different from what one might expect. Industries take advantage of these different properties. Nanoparticles in tennis rackets and snow skis enhance their strength. We use nanoparticles of zinc oxide or titanium dioxide in sunscreen to more effectively absorb the ultraviolet light rays and protect the skin. Nanoscale silver is an effective antibacterial agent and is woven into fabrics and clothes to keep them from smelling.

Tell us more about the use of nanotech in the oil and gas industry.

Read the original here:

Jay Kipper and Sean Murphy on nanotechnology in oil and gas production

FARMINGTON, Conn., April 1, 2013 /PRNewswire-iReach/ -- Research activities in healthcare have changed significantly in recent years. There has been a paradigm shift away from blockbusters drugs to a more personalized medicine approach. The focus is being placed increasingly on formulating drugs based on the individual's unique genome and immune response. Personalized medicines have gained significant popularity because they enable the medical profession to provide customized treatment to patients. Customized treatment is based on the genetic as well as medical profile of a patient. Increasing knowledge about the molecular causes of diseases is increasing the demand for more targeted and effective nanotechnology-enabled drug delivery therapies.

(Photo: http://photos.prnewswire.com/prnh/20130401/CG86396)

Research analysts at Infiniti Research predict that the nanotechnology drug delivery market in the U.S. will grow at a compound annual growth rate of 84.79 percent through 2016. One of the most important applications of nanotechnology in medicine currently being developed involves employing nanoparticles to deliver drugs to specific types of cells (such as cancer cells). Nanotechnology drug delivery helps in delivering drugs directly to diseased cells, which allows direct treatment of those cells. This technique helps to avoid damage to healthy cells within the human body. Hence, drug delivery technology helps to increase the overall market success of a particular drug.

A new report, "Nanotechnology Drug Delivery Market in the US 2012-2016" finds that one of the main challenges is the increasing safety concerns. Studies have revealed that the use of various nanomaterials may cause a variety of toxic effects. Lack of FDA directives is another major factor hampering the growth of the Nanotechnology Drug Delivery market in the US.

Learn more about the US nanotechnology drug delivery market and the key vendors dominating this space including Alkermes plc, Celgene Corp., Novartis AG, and SkyePharma at http://www.giiresearch.com/report/infi265388-nanotechnology-drug-delivery-market-us.html

The global nanotechnology drug delivery market is expected to grow at a 73.97 percent CAGR through 2016. Report details and free sample pages for the global edition of the nanotechnology drug delivery market are available at http://www.giiresearch.com/report/infi264464-global-nanotechnology-drug-delivery-market.html

In the smart pill technology market, one of the key drivers in this market forecast to grow at 6.9% - is the significant rise in the number of people suffering from GI disorders, which is mainly a result of changing lifestyles and food habits. Consequently, there has been an increase in the diagnosis and treatment of GI disorders.

According to "Global Smart Pill Technology Market 2012-2016", the prevalence of GI diseases such as colorectal cancer and esophagitis has increased over time, leading to the need for screening procedures as many such diseases can be cured when detected early. It is estimated that colorectal cancer accounts for more than 10 percent of the total number of cancer cases worldwide. The increased need for screening for various GI diseases increases the scope for the usage of endoscopy devices. Moreover, since many healthcare institutions prefer endoscopes and smart pills for screening procedures for GI disorders, the growth of the market is expected to increase during the forecast period.

For more information and to view free sample pages, please visit http://www.giiresearch.com/report/infi265384-global-smart-pill-technology-market.html

View post:

Will Safety Concerns Slow Nanotechnology Drug Delivery Market Growth? Forecasts Predict 84.79% Growth in US, 73.97 ...

22C3 - Nanotechnology

By: HackersOnBoard

Read the original here:

22C3 - Nanotechnology - Video

ULTRA RADIO FREQUENCY TREATMENT - NANOTECHNOLOGY

By: Eman Campos

Read this article:

ULTRA RADIO FREQUENCY TREATMENT - NANOTECHNOLOGY - Video

A survey in London reveals that most Britons have no idea what nanotechnology is and the rest think it will have a beneficial effect in the future

News |

LONDON: Most Britons have never heard of Nanotechnology and have no idea what it is, according to a survey released.

But the majority of the 29 per cent of people questioned in the poll who were aware of it think the ultra-small scale technology will have a beneficial effect in the future.

The survey was carried out by the Royal Society, an academy of leading scientists and the Royal Academy of Engineering.

"Nanotechnology involves studying and working with matter at an ultra-small scale, and a nanometer is just one-millionth of a millimeter in length. It is not really a shock to discover that most people have not heard about nanotechnology, because it is still a relatively young field," said Professor Nick Pidgeon, a member of a scientific working group on nanotechnology.

Only 19 per cent of the 1,005 adults in Britain who participated in the poll were able to give some sort of definition of nanotechnology. Sixty-nine percent of people who had an idea of what it was said it would make things better in the future.

Nanotechnology has fascinated scientists with its possibilities to develop minuscule computers and tiny medical devices. But it has also inspired fears about the dangers of nanoparticles and a fictional account of a plague of self-replicating robots turning the world into gray goo.

Two workshops conducted with the public to explore their views about the technology revealed that people reacted both positively and negatively when it was explained to them.

People thought it would be useful in medicine for early diagnosis and treatment but had concerns about its reliability and long-term potential side effects.

Go here to read the rest:

Brits ignorant of Nanotechnology

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/rcp9ds/global) has announced the addition of the "Global Nanotechnology Drug Delivery Market 2012-2016" report to their offering.

TechNavio's analysts forecast the Global Nanotechnology Drug Delivery market to grow at a CAGR of 73.97 percent over the period 2012-2016. One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Pharmaceutical and biotechnology companies are focusing on capitalizing on the potential of nanotechnology-enabled drug delivery. Nanotechnology-enabled drug delivery systems are helping pharmaceutical and biotechnology companies to counter the threat of generics. Reformulation helps in extending the product life cycle, and novel reformulations help an existing drug candidate to qualify as a new chemical entity. This increases profitability and discourages competition during the drug's most profitable years.''

According to the report, increasing government funding is one of the major drivers in the Global Nanotechnology Drug Delivery market. Government programs in various countries such as the US, the UK, Germany, and China exist for funding various R&D initiatives in nanotechnology, which is boosting the growth of the market.

Further, the report states that various manufacturing issues constitute one of the major challenges in the Global Nanotechnology Drug Delivery Market.

The key vendors dominating this space are IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc.

The other vendors mentioned in the report are Merck & Co. Inc., Pfizer Inc., AlphaRx Inc., Amgen Inc., Angiotech Pharmaceuticals Inc., Biophan Technologies Inc., Calando Pharmaceuticals Inc., Cephalon Inc., Cerulean Pharma Inc., Copernicus Therapeutics Inc., CritiTech Inc., CytImmune Sciences Inc., Elan Corp. plc, Debiotech SA, F. Hoffmann-La Roche Ltd., Nano Interface Technology Inc., Spherics Inc., Spectrum Pharmaceuticals Inc., SoluBest Ltd., Sigma-Tau Pharmaceuticals Inc., PharmaNova Inc., Particle Sciences Inc., Novavax Inc., Nanotherapeutics Inc., NanoSight Ltd., NanoCarrier Co. Ltd., NanoBioMagnetics Inc., Nano Interface Technology Inc., Merck Sharp & Dohme Corp., Kuecept Ltd., and Izon Science Ltd.

Key questions answered in this report:

- What will the market size be in 2016 and what will the growth rate be?

Read the original:

Research and Markets: Global Nanotechnology Drug Delivery Market 2012-2016: IOTA NanoSolutions Ltd., Lena Nanoceutics ...

Mar. 21, 2013 In a new discovery that represents a major step in solving a critical design challenge, Arizona State University Professor Hao Yan has led a research team to produce a wide variety of 2-D and 3-D structures that push the boundaries of the burgeoning field of DNA nanotechnology.

The field of DNA nanotechnology utilizes nature's design rules and the chemical properties of DNA to self-assemble into an increasingly complex menagerie of molecules for biomedical and electronic applications. Some of the Yan lab's accomplishments include building Trojan horse-like structures to improve drug delivery to cancerous cells, electrically conductive gold nanowires, single molecule sensors and programmable molecular robots.

With their bio-inspired architectural works, the group continues to explore the geometrical and physical limits of building at the molecular level.

"People in this field are very interested in making wire frame or mesh structures," said Yan. "We needed to come up with new design principles that allow us to build with more complexity in three dimensions."

In their latest twist to the technology, Yan's team made new 2-D and 3-D objects that look like wire-frame art of spheres as well as molecular tweezers, scissors, a screw, hand fan, and even a spider web.

The Yan lab, which includes ASU Biodesign Institute colleagues Dongran Han, Suchetan Pal, Shuoxing Jiang, Jeanette Nangreave and assistant professor Yan Liu, published their results in the March 22 issue of Science.

The twist in their 'bottom up,' molecular Lego design strategy focuses on a DNA structure called a Holliday junction. In nature, this cross-shaped, double-stacked DNA structure is like the 4-way traffic stop of genetics -- where 2 separate DNA helices temporality meet to exchange genetic information. The Holliday junction is the crossroads responsible for the diversity of life on Earth, and ensures that children are given a unique shuffling of traits from a mother and father's DNA.

In nature, the Holliday junction twists the double-stacked strands of DNA at an angle of about 60-degrees, which is perfect for swapping genes but sometimes frustrating for DNA nanotechnology scientists, because it limits the design rules of their structures.

"In principal, you can use the scaffold to connect multiple layers horizontally," [which many research teams have utilized since the development of DNA origami by Cal Tech's Paul Rothemund in 2006]. However, when you go in the vertical direction, the polarity of DNA prevents you from making multiple layers," said Yan. "What we needed to do is rotate the angle and force it to connect."

Making the new structures that Yan envisioned required re-engineering the Holliday junction by flipping and rotating around the junction point about half a clock face, or 150 degrees. Such a feat has not been considered in existing designs.

See original here:

Scientists develop innovative twists to DNA nanotechnology

DETROIT, March 20, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (CTLE) is pleased to report that Dr. Victor Castano, Chief Innovations Officer of Nano Labs, presented "A nanotechnology approach to immunology: challenges and opportunities." at the Target Meeting ("TM") 2nd World Immunology Online Conference.

The TM 2nd World Immunology Online Conference, held March 19-21, 2013, included sixty (60) international speakers over the three (3) day conference, providing speakers and attendees with in-depth discussion, collaboration and networking.

Dr. Castano's presentation included a historical review of how nanostructures, both natural and man-made, have played important roles in immunology, emphasizing the challenges and advantages that are present through novel nanoscale approaches.

Dr. Castano further presented a number of Nano Labs' projects currently underway, including using state-of-the art technologies, such as MEMS and NEMS, for immunological applications, discussing the potential limitations and challenges that such techniques pose for the practicing immunologists. (For further reading, please refer to Nano Labs' press release of March 4, 2013, entitled "Nano Labs Develops Diagnostic Technology to Identify Tuberculosis (TB) Through Novel Nanotechnologies. Researchers Present Industry With Promising Diagnostic Test Results Identifying TB Through Nano Biosensors".)

"The online conference was a great success. You have to appreciate how so many internally recognized experts can come together in an innovative and informative fashion, all without the travel and expense, to collaborate and exchange ideas," stated Dr. Castano. "Our tuberculosis detector was very well received and attracted a lot of attention from American and European organizations interested in continuing discussions. There are many remarkable and major developments happening in the life sciences sector that are game changing right now and we look forward to being a part of that."

About Target Meeting and the 2nd World Immunology Online Conference

Target Meeting is a leading online life science conference organizer developing many specialized conferences, seminars, and workshops to meet researcher's specific needs and requirements around the world. It will bring together leading professors, researchers, and life science suppliers worldwide to discuss the latest discovery of biomedical research. Through our well-organized conferences, seminars, or workshops, we have already built a good reputation in the field of life science. Target Meeting provides outstanding opportunities for scientists to share latest research, to inspire breakthrough ideas, and to establish and maintenance academic relationships through extensive interactions. For more information please visit http://www.TargetMeeting.com.

About Nano Labs

Nano Labs Corp. (CTLE) is a nanotechnology company which began during October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. The Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit http://www.NanoLabs.us.

The Nano Labs Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=16293

View post:

Nano Labs Presents "A Nanotechnology Approach to Immunology: Challenges and Opportunities" at World Immunology ...

FARMINGTON, Conn., March 19, 2013 /PRNewswire-iReach/ -- 2012 continued to see major advances that were enabled by nanotechnology. In medicine in particular the delivery methods wrapped within nanoparticles have advanced many new and traditional drugs further along the clinical trial pipeline. Nano-engineering has also increased its grip on semiconductor manufacturing, and a multitude of quality control subsystems.

(Photo: http://photos.prnewswire.com/prnh/20130319/CG79773)

BCC Research's "Nanotechnology Research Review" provides an overview of the market for nanoparticles in the life sciences on a global basis including description of leading and emerging drug products, major players in nanoparticle drug delivery field and methods of nanoparticle formation. The report also provides an overview of nanocomposites, nanoparticles, nanoclays and nanotubes as well as carbon nanotubes.

Learn more and request free sample pages from the full report at http://www.giiresearch.com/report/bc228065-2011-nanotechnology-research-review.html

In "Global Nanotechnology Drug Delivery Market 2012-2016", industry experts forecast that the nanotechnology drug delivery market will grow 73.97 percent through 2016. The key vendors dominating this space are IOTA NanoSolutions Ltd., Lena Nanoceutics Ltd., GlaxoSmithKline plc, Celgene Corp., and SkyePharma plc.

One of the key factors contributing to this market growth is the low R&D cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market.

Learn more and request free sample pages from the full report at http://www.giiresearch.com/report/infi264464-global-nanotechnology-drug-delivery-market.html

Drug Discovery Chemistry 2013 is coming to San Diego on April 16, 2013. The event features six conferences in one location, more than 100 technical presentations, exclusive exhibit and poster viewing hours, interactive roundtable, breakout and panel discussions, case studies, best practices, 400 high-level participants, and dedicated networking opportunities. Learn more and register today at http://www.giiconference.com/chi252870-2013/

Drug Discovery & Therapy World Congress 2013 is taking place this June in Boston. This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics.

For more information and to register visit http://www.giiconference.com/eur243545-2013/

See the original post here:

Nanotechnology Market Research Review and Conference Opportunities

Dr Anna Demming, Nanotechnology editor
wwwyoutubecombbcexpertwomen Anna Demming is a science writer and editor Her work covers all areas of science with particular emphasis on nanotechnology and developments in electronics and photonics She has a phd in nanophotonics and 7 years experience in science editorial and journalism for publishers including Nature Publishing Group and IOP Publishing While currently working with IOP Publishing focusing on their journals Nanotechnology and Journal of Physics Condensed Matter she ...

By: SWDanceTheatre

Link:

Dr Anna Demming, Nanotechnology editor - Video

"Semiconductor Nanotechnology" by Dr. Jerzy Ruzyllo
You need Adobe Flash Player to watch this video. Download it from Adobe. Semiconductor Nanotechnology by Dr Jerzy Ruzyllo. psuscienceu9 videos. Subscribe Subscribed Unsubscribe 0. No views. Like 0 Dislike 0. Like. Sign in to youtube. Sign in with your youtube Accountyoutube Google+ Gmail Orkut Picasa or Chrome to like psuscienceus video. Sign in. I dislike this. Sign in to youtube. Sign in with your youtube Accountyoutube Google+ Gmail Orkut Picasa or Chrome to dislike psuscienceus video ...

By: PSUScienceU

More here:

"Semiconductor Nanotechnology" by Dr. Jerzy Ruzyllo - Video

Barbara Herr Harthorn, "Nanotechnology and Gender Implications"
From the 2009 Nanoethics Graduate Education Symposium, part of the first annual meeting of the Society for the Study of Nanoscience and Emerging Technologies...

By: engrUW

Read more here:

Barbara Herr Harthorn, "Nanotechnology and Gender Implications" - Video

Simpson College - DNA Nanotechnology Research
Alert icon. You need Adobe Flash Player to watch this video. Download it from Adobe. Simpson College DNA Nanotechnology Research. Prof Lyons1 video. Subscribe Subscribed Unsubscribe 0. 2 views. Like 0 Dislike 0. Like. Sign in to youtube. Sign in with your youtube Accountyoutube Google+ Gmail Orkut Picasa or Chrome to like Prof Lyonss video. Sign in. I dislike this. Sign in to youtube. Sign in with your youtube Accountyoutube Google+ Gmail Orkut Picasa or Chrome to dislike Prof Lyonss video ...

By: Prof Lyons

Read the original:

Simpson College - DNA Nanotechnology Research - Video

NASA targets nanotechnology for space exploration
Meyya Meyyappan is the director of the Center for Nanotechnology at NASA Ames Research Center. In this video interview with Physics World, Meyyappan explains...

By: NanotechnologyVideo

Read the original:

NASA targets nanotechnology for space exploration - Video

Nanotechnology company in Homer moving to Canandaigua
Nanotechnology company in Homer moving to Canandaigua. Uploaded by cnycentralnews on Mar 12 2013. httpcnycentralcom. cnycentral News.

By: CNYCentralNews

See original here:

Nanotechnology company in Homer moving to Canandaigua - Video

NEW YORK, March 13, 2013 /PRNewswire/ --

Touch Panel Transparent Conductive Film: Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2019 http://www.reportlinker.com/p01120555/Touch-Panel-Transparent-Conductive-Film-Market-Shares-Strategies-and-Forecasts-Worldwide-Nanotechnology-2013-to-2019.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Nanotechnology

Transparent conductive film enables features of smart phones and electronics applications. Devices are evolving in response in part to the characteristics of the transparent conductive film that is used in the user interface. Products support collaboration. Solutions are competitive.

According to Susan Eustis, the principal author of the study, "The advantage of transparent conductive film is that a very thin layer of material as a coating on a surface can provide touch screen capability. Transparent conductive film supports electronic device usability. Factors that influence commercial success in the wireless device and services market relate to usability above all: The designs of the iPhone are genius designs because of the usability they bring. Development of an integrated hardware, software and service platform to support multiple wireless network standards is an essential aspect of market participation."

The transparent conductive film markets are leveraging the expanding market opportunities related to mobile communication and media devices of smart phones and tablets among others. Transparent conductive film provides the base for device navigation by recognizing the presence of a finger as it moves across a screen. That navigation supports transmission of digital data into and out of the smart phone. The transparent conductive film markets are highly competitive. The competition is expected to intensify significantly as new technologies evolve.

Transparent conductive film principal competitive factors include price, product features, relative price/performance, product quality and reliability, design innovation, marketing and distribution capability, service and support, and corporate reputation. Indium tin oxide (ITO) has been the prevailing transparent conductive film used in touch screen applications. It requires an expensive and cumbersome sputtering deposition process. The price of indium is increasing rapidly and the film is rigid. There is demand for more flexible film in the market.

The Touch Panel Transparent Conductive Film TCF market is $956 million in 2012. Markets are anticipated to reach $4.8 billion by 2019. ITO is an entrenched technology for display manufacturing. Indium tin oxide (ITO) has been the transparent conductive film technology for touch screens. Newer technology will erode ITO and provide improved functionality as lower prices. Transparent conductive film supports electronic device usability.

WinterGreen Research is an independent research organization funded by the sale of market research studies all over the world and by the implementation of ROI models that are used to calculate the total cost of ownership of equipment, services, and software. The company has 35 distributors worldwide, including Global Information Info Shop, Market Research.com, Research and Markets, Bloomberg, and Thompson Financial.

Table of Contents

Transparent Conductive Film - Executive Summary ES-1

Read this article:

Touch Panel Transparent Conductive Film: Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology , 2013 to ...

LAS CRUCES Micro and Nanotechnology Commercialization and the Procurement Technical Assistance Program will be subjects for the next meeting of the High Tech Consortium of Southern New Mexico.

The meeting is set for 11:30 a.m. to 1 p.m. on Friday at Hotel Encanto de Las Cruces.

There will be two presentations to the membership - Mr. William Hett-Dobricky with Doa Ana Community College and Mr. Scott Bryant of Nano-Network of New Mexico

Hett-Dobricky will discuss the Procurement Technical Assistance Program (PTAP) and the services and programs offered to small businesses in Dona Ana and Sierra counties.

Bryant, President of the Nano-Network of New Mexico will discuss Micro and Nanotechnology Commercialization, current trends in Nanotechnology and the opportunities for southern New Mexico. Today's developments in Nano and biotechnologies are increasingly relying on global connections, starting from early R&D to final development stages. Convergence is the operative keyword as this trend forges alliances between semiconductors and chemical companies, between pharmaceuticals and biology, between IT and energy technologies, and on a broader technological level, between nanotechnologies and biotechnologies.

Bryant will introduce the NanoTox Academy, together with the Bioscience Center, and will discuss the Western Region Nanotechnology OEHS Mini Boot Camp designed specifically for those professionals who oversee Engineered Nanomaterial (ENM) operations

HTC membership meetings are open to the public and free; anyone interested in growing high technology in southern New Mexico is encouraged to attend. For more information call Terry Jack at 575-522-3868 or email terry@imac.us.com.

Read the original here:

Nanotechnology , PTAP subjects for HTC meeting

AUSTIN, TX--(Marketwire - Mar 13, 2013) - SOUTH BY SOUTHWEST (SXSW) -- Liquipel, LLC, makers of the award-winning Watersafe nanotechnology that protects your electronics from accidental water damage, will be at the Empire Garage and Control Room during South by Southwest. They will be showcasing their newly debuted Liquipel 2.0 nanocoating technology for mobile phones, headphones, microphones and more.

Liquipel will demonstrate the Liquipel 2.0 technology, which represents the latest in nanocoating science, technology and manufacturing process with marked improvements on durability, corrosion resistance and water protection from its predecessor. Liquipel's patent-pending process creates a liquid-repellant coating, that is microscopic and forever lasting because the coating becomes a part of the device. The coating is virtually untraceable and will not affect, nor compromise the look, feel and performance of the device.

"We are committed to getting this revolutionary technology in the hands of consumers everywhere," said Kevin Bacon, co-founder and chief operating officer of Liquipel. "This year we expanded our portfolio of products, and through Liquipel 2.0, we are delivering on our promise to advance our technology and products."

Where to find Liquipel Liquipel staff will be at the Empire Garage and Control Room (606 East 7th St. Austin, TX 78702) from March 12-16 from 1pm-6pm. For appointments, please email liquipel@socialradius.com.

About LiquipelLiquipel, LLC is the sole owner and licensor of Liquipel, an award-winning formulation and manufacturing process that uses nanotechnology to make smartphones and other devices Watersafe from accidental exposure to water and other liquids. Since its debut at the Consumer Electronics Show 2012, it has won an Edison Award, a FierceWireless Fierce 15 Award, was named by Popular Science the Grand Award Winner in the Gadgets Category in the magazine's "Best of What's New" issue, and has also been included in Entrepreneur Magazine's "100 Brilliant Companies" list. For more information and videos, please visit Liquipel's website, and follow us on Facebook and Twitter. To contact Liquipel, LLC, email info@liquipel.com.

See more here:

Liquipel Demonstrates the Latest in Liquid Protection Nanotechnology at SXSW